Abstract
To determine whether angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) initiation in people with diabetes is monitored as recommended by recent guidelines and the incidence of associated adverse renal events.
Original language | English |
---|---|
Pages (from-to) | 69-76 |
Number of pages | 8 |
Journal | Scottish Medical Journal |
Volume | 58 |
Issue number | 2 |
DOIs | |
Publication status | Published - May 2013 |
Keywords
- Aged
- Aged, 80 and over
- Analysis of Variance
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Creatinine
- Diabetes Mellitus, Type 2
- Drug Monitoring
- Electrolytes
- Female
- General Practice
- Humans
- Hyperkalemia
- Logistic Models
- Male
- Middle Aged
- Retrospective Studies